Laryngeal Neoplasms: all 248 studies

Page 3 of 3. Open to participants first (64), then studies with results posted, then the rest; newest registration first within each.

• Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck CancerCompletedNCT01084733
• Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal CancerStatus unknownNCT01073683Phase 2
• Effects of Swallowing Exercises on Patients Undergoing Radiation Treatment for Head and Neck CancerTerminatedNCT01053546Not applicable
• MRI Laryngeal Imaging With a Surface CoilTerminatedNCT00965003Early Phase 1
• Safety and Efficacy Study in Patients With Local Advanced Larynx/Hypolarynx Carcinoma Treated With TPF Induction Chemotherapy Followed by Hyperfractionated Radiotherapy With CetuximabTerminatedNCT00941135Phase 2
• Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00906360Phase 1
• Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal CancerCompletedNCT00827164Phase 2
• TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx CancerCompletedNCT00765011Phase 2
• Functional Voice and Speech Outcomes Following Surgical Voice Restorations: A Comparison of Pharyngeal Construction ApproachesCompletedNCT00600223
• The Objective is to Respond to Patients' Needs in the Field of Larynx ReplacementCompletedNCT00576134Phase 1
• Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CACompletedNCT00534729Not applicable
• Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck CancerCompletedNCT00470496Phase 1
• Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy PatientsCompletedNCT00467948Phase 3
• Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
• Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or PharyngolaryngectomyStatus unknownNCT00396617Phase 1
• Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk PopulationCompletedNCT00359645Phase 3
• The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell CarcinomaStatus unknownNCT00302562
• The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell CarcinomaStatus unknownNCT00174096
• The Role of Lymphangiogenesis in Head and Neck Cancer MetastasisStatus unknownNCT00173381
• Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx PreservationCompletedNCT00169247Phase 2
• Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx CarcinomaCompletedNCT00169182Phase 3
• Very Intense Radiotherapy-chemotherapy Regimen in Advanced HNSCCCompletedNCT00162708Phase 2/3
• Patient Selection for Hypoxia Modifying Treatments in Larynx CarcinomasCompletedNCT00160095
• Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCCCompletedNCT00158652Phase 3
• Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal CancersTerminatedNCT00128817Phase 3
• Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their ConfidantsCompletedNCT00127465Phase 1/2
• Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00114283Phase 2
• Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00101348Phase 1/2
• Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerCompletedNCT00098631Phase 2
• S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00096512Phase 2
• Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00089362Phase 1
• Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00081211Phase 1
• Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck CancerTerminatedNCT00080028Phase 1
• Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerCompletedNCT00068497Not applicable
• Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and NeckCompletedNCT00063895Phase 1/2
• Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00055913Phase 1/2
• Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck CancerCompletedNCT00055770Phase 1/2
• Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerCompletedNCT00049283Phase 1
• Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and NeckCompletedNCT00033618Phase 2
• Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck CancerTerminatedNCT00033449Phase 1
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
• Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy PatientsCompletedNCT00026975Phase 2
• Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerCompletedNCT00023959Phase 1
• Patient Evaluation for Head and Neck Surgery Branch StudiesTerminatedNCT00011492
• Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal CancerCompletedNCT00004256Phase 2
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• The Effects of Upper Airway and Digestive Tract Tumors on the Immune SystemCompletedNCT00001603

← Laryngeal Neoplasms overview